Lodha Developers to file DRHP to launch IPO
Lodha Developers to file DRHP to launch IPO

Lodha Developers to file DRHP to launch IPO

Nikita Singh Article rating: 5.0

Real estate major Lodha Developers is buckling up to file its draft prospectus with SEBI to launch its IPO soon, according to reports. The initial public offering is expected to be one of the most notable debuts in the Indian stock this year. 

Overnight Digest: Stocks to look out for on May 3
Overnight Digest: Stocks to look out for on May 3

Overnight Digest: Stocks to look out for on May 3

Nikita Singh Article rating: 5.0

The stocks that are expected to witness a significant movement on the bourses on Thursday, May 3, 2018 are Cadila Healthcare Limited, Tata Power Company Limited, Kridhan Infra Limited, Castrol India Limited and Central Bank of India.      

GR Infraprojects files DRHP for IPO
GR Infraprojects files DRHP for IPO

GR Infraprojects files DRHP for IPO

Nikita Singh Article rating: 5.0

Real estate company GR Infraprojects filed draft papers with the market regulator SEBI to raise about Rs. 1,800 crore via an initial public offering (IPO). 

Uflex launches one of a kind Flexi-Tube OPTIKA
Uflex launches one of a kind Flexi-Tube OPTIKA

Uflex launches one of a kind Flexi-Tube OPTIKA

Nikita Singh Article rating: 5.0

In a significant development, packaging major Uflex has introduced Flexi-Tubes that roll up all the advantages of multi-layered flexible laminates to perfection. 

Overnight Digest: Stocks to look out for on April 27
Overnight Digest: Stocks to look out for on April 27

Overnight Digest: Stocks to look out for on April 27

Nikita Singh Article rating: 5.0

The stock that are most likely to witness a significant movement on the bourses on April 27, 2018 are The Phoenix Mills Limited, Accelya Kale Solutions Limited, Thermax Limited, Cyient Limited, Cholamandalam Investment and Finance Company Limited

Cadila Healthcare surges on bagging USFDA approval
Cadila Healthcare surges on bagging USFDA approval

Cadila Healthcare surges on bagging USFDA approval

Nikita Singh Article rating: 5.0

Pharma major Zydus Cadila surged by over 3 per cent on the bourses on Thursday as the company bagged the final approval from the US Food and Drug Administration (USFDA) for marketing Methylprednisolone Cinacalcet Hydrochloride tablets.

RSS
123468910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR